August 2, 2018
Copenhagen, Denmark – Anapa Biotech (“Anapa”; www.meltplex.com) is a Copenhagen - based company with novel intellectual property and a first-in-class approach to ultrahigh performance multiplexing for molecular diagnostic assays. Following a strategic review and four years of technical development and IP filing, Anapa is pleased to announce that it is working with The Sage Group [...]
Certara Software or Services Supported 95% of the US FDA Novel Drug Approvals in First Half of 2018
August 2, 2018
Modeling and simulation’s positive impact on NDA and BLA approvals through July 1, 2018 has included first use, orphan and priority review drugs for multiple indications PRINCETON, NJ – Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today reported that 95% of novel new drug approvals by the [...]
A rock solid future with Solid.Line
August 2, 2018
Our research and development (R&D) team has been working hard on another new product line, coming up with something that is truly rock solid: Solid.Line. The new line of drying and heating chambers and incubators offers users the perfect complement to the proven premium products provided by BINDER. User who regularly carry out their tests in a specific [...]
New “AP225W” Semi-micro Analytical Balance Enables Measurements up to 220 g on the Order of 0.01 mg
August 1, 2018
Shimadzu announces the release of its "AP225W" semi-micro analytical balance. While being capable of measuring up to 220 g, it also features a minimum reading of 0.01 mg (1/100,000th of a gram). This high-end model completes measurements in approximately two seconds, and can measure up to 220 g on the order of 0.01 mg. Using the [...]
JOE MILLER, VICE PRESIDENT OF CHEMISTRY AND STRATEGY
August 1, 2018
Regis is proud to welcome Joe MIller, Ph.D. to the new senior leadership role of Vice President of Chemistry and Strategy. Joe will align our core chemical development groups: Process Research, Process Development, and Analytical Method Development into one cohesive customer-focused team and deliver great solutions to our customers. Joe received his Ph.D. in 1982 [...]
Robert Wicke Appointed as New CEO of Halo Labs
August 1, 2018
SAN FRANCISCO -- Halo Labs, a venture-backed scientific instrumentation company developing high-throughput biopharmaceutical quality control tools, today announced the appointment of Robert Wicke as Chief Executive Officer. Robert is a seasoned executive with over 25 years of experience growing successful life science instrumentation companies through the commercialization of innovative new products and inorganic growth. Prior to joining Halo Labs, [...]
BIO-TECHNE CORPORATION COMPLETED ITS ACQUISITION OF EXOSOME DIAGNOSTICS, INC.
August 1, 2018
MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed its acquisition of Exosome Diagnostics, Inc. The transaction consideration includes an upfront payment of $250 million plus an additional $325 million that can be maximally earned through calendar year 2022 upon reaching certain performance milestones. With this acquisition, Minneapolis-based Bio-Techne now has a world-wide workforce [...]
August 1, 2018
FREDERICK, MD. FOR IMMEDIATE RELEASE: RURO, Inc., a company known for its industry-leading laboratory software portfolio, announces the release of Limfinity® version 7.1. Limfinity® is the software framework that all of RURO’s products are built from, and each improvement made to Limfinity® itself creates new possibilities for both current users and the future of RURO’s [...]
William Franco Joins VUV Analytics as Vice President of Engineering
August 1, 2018
Austin, TX – VUV Analytics, Inc., the leader in vacuum ultraviolet (VUV) absorption spectroscopy, has announced the addition of William Franco as Vice President of Engineering. Mr. Franco has an established track record of leading engineering teams at highly successful startups and larger companies, including LifeSize, TippingPoint, National Instruments, and Cisco. Most recently, he was [...]
BD Appoints Simon Campion to Interventional Segment President
August 1, 2018
FRANKLIN LAKES, N.J.-- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today appointed Simon Campion as executive vice president of BD and president, BD Interventional segment, effective Sept. 4. Campion, 47, will report to Tom Polen, president of BD, and will be responsible for the global strategic, operational and commercial performance of the [...]
